RVL Pharmaceuticals
Jen Polick is an accomplished sales professional with extensive experience in the pharmaceutical and healthcare industries. Currently serving as a Specialty Account Manager at Axsome Therapeutics, Inc. since October 2022, Jen has previously held the role of Territory Manager at RVL Pharmaceuticals, Inc. since October 2021. Jen's career includes significant positions such as Territory Business Manager at Circassia Pharmaceuticals, where responsibilities included promoting specialty respiratory products to various healthcare professionals, and Account Manager at Option Care, focusing on home infusion therapies. Jen's earlier roles as Territory Manager at Soleo Health and Coram Specialty Home Infusion further demonstrate expertise in building relationships within the healthcare sector. Jen's career began as a Pharmaceutical Sales Executive at Andrx Pharmaceuticals and a Pharmaceutical Sales Representative at Reliant Pharmaceuticals. Jen holds a Bachelor's degree in Communications and Finance from Western Michigan University.
This person is not in any offices
RVL Pharmaceuticals
RVL Pharmaceuticals plc is a specialty pharmaceutical company focused on the commercialization and development of products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas. The Company is currently commercializing UPNEEQ® (oxymetazoline hydrocholoride ophthalmic solution), 0.1%, for the treatment of acquired blepharoptosis, or low-lying eyelid, in adults. UPNEEQ is the first non-surgical treatment option approved by the FDA for acquired blepharoptosis.